Gout — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for gout. 63 active patents protecting 3 drugs from 2+ originators. First major cliff: 2028. Daily refresh.

3
Approved drugs
63
Active US patents
64/100
Avg vulnerability
—
Annual revenue covered

Originators in Gout

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Scilex Pharms 41 patents Casper Pharma Llc 16 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating gout. Each bar = one year. Y-axis scaled to peak year (17 patents).

15
28
12
29
6
30
4
31
2
32
17
33
1
34
5
36
1
37

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Colcrys
COLCHICINE
 Scilex Pharms 41 72 — 2028-10-06
Aloprim
ALLOPURINOL
 Casper Pharma Llc 16 63 — 2028-11-26
Indocin Sr
INDOMETHACIN
 — 6 56 — 2030-04-23

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8415395 Colcrys method of use 80 2028-10-06
8093297 Colcrys method of use 80 2028-10-06
8093298 Colcrys method of use 80 2028-10-06
7964648 Colcrys method of use 80 2028-10-06
8093296 Colcrys method of use 80 2028-10-06
7981938 Colcrys method of use 80 2028-10-06
8415396 Colcrys method of use 80 2028-10-06
8097655 Colcrys method of use 80 2028-10-06
7964647 Colcrys method of use 80 2028-10-06
7619004 Colcrys method of use 80 2028-12-03

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8546436 Aloprim composition of matter 10 2032-02-29
8546436 Aloprim composition of matter 10 2032-02-29
10226423 Colcrys formulation 42 2037-12-20
9907751 Colcrys formulation 42 2036-11-22
10383821 Colcrys formulation 42 2036-11-22
8992982 Indocin Sr formulation 48 2030-04-23
8992982 Indocin Sr formulation 48 2030-04-23
8734847 Indocin Sr formulation 53 2030-04-23
8734847 Indocin Sr formulation 53 2030-04-23
10383820 Colcrys method of use 62 2036-11-22

Related